Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)

Vaxcell-Bio Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	213,968	239,819	516,197	519,865	660,678	2,517,196
Market Cap Growth	-35.87%	-53.54%	-0.71%	-21.31%	-73.75%	-
Enterprise Value	175,923	192,973	504,030	497,951	646,323	2,482,604
Last Close Price	9200.00	10430.00	22450.00	26694.20	33924.69	130774.23
PS Ratio	-	126.29	37614.61	-	-	-
PB Ratio	-	3.33	6.18	22.29	21.96	72.61
P/TBV Ratio	-	3.57	6.20	22.51	22.07	72.75
EV/Sales Ratio	-	101.62	36727.98	-	-	-
Debt / Equity Ratio	0.03	0.03	0.00	0.01	0.01	0.01
Asset Turnover	0.02	0.02	0	-	-	-
Inventory Turnover	9.19	9.19	-	-	-	-
Quick Ratio	13.45	13.45	54.78	67.10	70.51	31.98
Current Ratio	13.87	13.87	55.43	68.06	71.88	32.29
Return on Equity (ROE)	-13.66%	-13.66%	-19.24%	-25.56%	-14.71%	-18.22%
Return on Assets (ROA)	-11.64%	-11.64%	-13.18%	-18.52%	-11.05%	-11.68%
Return on Capital (ROIC)	-11.92%	-11.92%	-13.41%	-19.11%	-11.30%	-11.94%
Earnings Yield	-	-4.43%	-1.99%	-1.31%	-0.72%	-0.16%
FCF Yield	-	-5.35%	-1.86%	-1.20%	-1.03%	-0.13%
Buyback Yield / Dilution	-17.03%	-17.03%	-28.80%	-0.68%	-122.02%	-55.35%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.